Higashiosaka, Japan

Hideaki Matsuda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fuso Pharmaceutical Industries, Ltd., Kinki University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Matsuda. Retrieved from https://idiyas.com/inventor/hideaki-matsuda-2ip2iv6k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hideaki Matsuda

Introduction

Hideaki Matsuda is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on calcium channel inhibitors. His research and inventions have the potential to impact therapeutic approaches for various diseases.

Latest Patents

Matsuda holds a patent for a T-type calcium channel inhibitor. This invention provides a compound represented by a specific formula, which includes pharmaceutically acceptable salts and solvates. The T-type calcium channel inhibitor is designed to serve as a therapeutic or prophylactic agent for diseases that benefit from T-type calcium channel inhibition.

Career Highlights

Throughout his career, Matsuda has worked with esteemed institutions such as Kinki University and Fuso Pharmaceutical Industries, Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical products.

Collaborations

Matsuda has collaborated with notable colleagues, including Atsufumi Kawabata and Fumiko Sekiguchi. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Hideaki Matsuda's contributions to the field of pharmaceuticals, particularly through his patent for a T-type calcium channel inhibitor, highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research and development in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…